Bafna Pharmaceuticals Ltd.

₹99.16

-4.6 (-4.5%)

BAFNAPH Share Price

Pharmaceuticals & Biotechnology

As on March 13, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 233 Cr

P/E Ratio-10.81

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	105.01	Bearish
10-DMA	106.76	Bearish
20-DMA	110.34	Bearish
50-DMA	120.01	Bearish
100-DMA	137.52	Bearish
200-DMA	120.87	Bearish

Historical Performance

1 Year

22.8%

3 Years

6.6%

5 Years

-28.9%

10 Years

187.4%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2020	Mar-2019	Mar-2018	Mar-2017	Mar-2016
Net Sales	425	436	472	650	853
Total Expenditure	412	567	823	708	848
Other Income	3	4	313	11	20
Operating Profit	15	-127	-38	-47	25
Interest	1	21	69	115	130
Depreciation	33	35	40	42	49
Profit Before Tax	-19	-183	-147	-204	-153
Consolidated Net Profit	-247	-189	-167	-191	-140
Adjusted EPS	-9	-8	-7	-10	-8

Compounded Sales Growth

10 Years:-13

5 Years:-13

3 Years:-8.1

TTM:-0.5

Compounded Profit Growth

10 Years:12

5 Years:12

3 Years:5.3

TTM:5.6

Stock Price CAGR

10 Years:12.2

5 Years:-7.5

3 Years:3.1

TTM:22.8

Return on Equity

10 Years:N/A

5 Years:-7.5

3 Years:-7.1

last year:-9.2

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2020	Mar-2019	Mar-2018	Mar-2017	Mar-2016
Share Capital	24	237	237	187	187
Total Reserves	-66	-46	143	200	391
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	30	298	413	547	399
Other Current Liabilities	46	80	79	142	100
Short Term Borrowings	---	232	233	434	453
Total Liabilities	713	1,195	1,384	1,783	1,925
Capital Work in Progress	2	---	---	---	---
Long Term Loans & Advances	---	330	442	350	---
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	27	54	63	11	336
Total Current Assets	361	485	487	772	1,223
Total Assets	713	1,195	1,384	1,783	1,925
Adjusted Book Value	-18	8	16	21	31

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -10.81, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of 3.1%, indicating poor shareholder returns.
The stock carries a low beta of 0.3, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹15 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹425 million, indicating a relatively small business scale.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1231954.3

No. of Shares: 12424 (Approx)

Performance:23.2%

P/L: ₹231954.3

NIFTY Performance: 3.4%

1 day Top Gainers